In June this year Sycamore House in Stevenage was the recipient of the Midlands and Central England region award within this category culminating in the national awards ceremony in London on the 3rd October.
News
Optimizing Smooth Muscle Cell Cryopreservation for Cardiovascular Research
AMSBIO, in collaboration with the University of Strathclyde (UK), announce the release of a poster that describes a comprehensive assessment of the effects of three different cryopreservation reagents (CELLBANKER® 1, CELLBANKER® 2 and commonly used 10% DMSO) on the viability and proliferative capacity of vascular smooth muscle cells (vSMCs)
Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization
|
Global specialist in temperature-controlled logistics for life sciences, Biocair, has been awarded a 2023 EcoVadis silver medal for its overall achievements in sustainability. This is the second year that Biocair has achieved the silver medal from the esteemed sustainability rating provider.
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization
Mursla Bio participates in a unique global initiative to standardise the clinical use of novel EV-based biomarkers for liquid biopsy
Alveron Pharma has successfully completed its first-in-human trial of OKL-1111, a new drug for the rapid treatment of intracranial haemorrhage associated with the use of anticoagulants or platelet inhibitors. The study was conducted at Hammersmith Medicines Research in London. OKL-1111 was well-tolerated in the trial with healthy human volunteers and showed no more adverse events above those in the placebo groups. Volunteers also received an anticoagulant and a pharmacodynamic effect was observed with OKL-1111 administration.